tiprankstipranks
Trending News
More News >
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Japanese Market
Advertisement

COSMOS Pharmaceutical Corporation (3349) Income Statement

Compare
0 Followers

COSMOS Pharmaceutical Corporation Income Statement

Last quarter (Q3 2024), COSMOS Pharmaceutical Corporation's total revenue was ¥246.33B, an increase of 3.12% from the same quarter last year. In Q3, COSMOS Pharmaceutical Corporation's net income was ¥7.92B. See COSMOS Pharmaceutical Corporation’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.01T¥ 964.99B¥ 827.70B¥ 755.41B¥ 726.42B
Gross Profit
¥ 213.28B¥ 188.31B¥ 168.72B¥ 151.45B¥ 145.11B
Operating Expenses
¥ 172.88B¥ 156.81B¥ 138.59B¥ 121.65B¥ 111.96B
Depreciation and Amortization
¥ 22.23B¥ 19.92B¥ 17.37B¥ 15.11B¥ 13.79B
EBITDA
¥ 64.86B¥ 53.74B¥ 50.19B¥ 48.21B¥ 46.93B
Operating Income
¥ 40.40B¥ 31.50B¥ 30.13B¥ 29.80B¥ 33.15B
Other Income/Expenses
¥ 1.97B¥ 2.22B¥ 2.65B¥ 3.25B¥ 5.45B
Pretax Income
¥ 42.37B¥ 33.72B¥ 32.77B¥ 33.05B¥ 38.60B
Net Income
¥ 30.98B¥ 24.45B¥ 23.80B¥ 23.16B¥ 27.16B
Per Share Metrics
Basic EPS
¥ 390.85¥ 308.61¥ 300.48¥ 292.37¥ 342.89
Diluted EPS
¥ 390.85¥ 308.61¥ 300.48¥ 292.37¥ 342.89
Weighted Average Shares Outstanding
79.26M 79.24M 79.20M 79.20M 79.20M
Weighted Average Shares Outstanding (Diluted)
79.26M 79.24M 79.20M 79.20M 79.20M
Currency in JPY

COSMOS Pharmaceutical Corporation Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis